Diamond Biofund Inc.

Research Diamond Biofund Inc. (6901.TW) on Bullrun: market cap TWD 15.01B, P/E 5.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 15.01B; P/E is 5.3.

Peer valuation comparison

Latest P/E is 5.25x versus a Financial Services sector median of 13.04x (59.7% below).

Latest P/E is 5.25x versus a Taiwan median of 18.67x (71.9% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 15.01B5.3n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Diamond Biofund Inc.

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

Related stock research

Taiwan stocks Taiwan Financial Services stocks A-Z stock index

Other Financial Services stocks

ABICO Asia Capital Corporation (7777.TWO) China Man-Made Fiber Corporation (1718.TW) Chang Hwa Commercial Bank, Ltd. (2801.TW) Taichung Commercial Bank Co., Ltd. (2812.TW) Union Insurance Co., Ltd. (2816.TW) China Bills Finance Corporation (2820.TW) Taiwan Fire & Marine Insurance Co., Ltd. (2832.TW) Taiwan Business Bank, Ltd. (2834.TW) Bank of Kaohsiung Co., Ltd. (2836.TW) Union Bank of Taiwan (2838.TW) Far Eastern International Bank Ltd. (2845.TW) EnTie Commercial Bank Co., Ltd. (2849.TW)

Frequently asked questions

What is Diamond Biofund Inc.'s market cap?

Diamond Biofund Inc.'s market capitalization is TWD 15.01B.

What is Diamond Biofund Inc.'s P/E ratio?

Diamond Biofund Inc.'s price-to-earnings (P/E) ratio is 5.3.

What does Diamond Biofund Inc. do?

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.